Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Registry for coronary artery disease and microvascular disease in cardiomyopathies

Official title: Coronary Artery Disease and Coronary Microvascular Disease in Cardiomyopathies Registry

Run by University Hospital, Grenoble · NCT03479580 · Data updated 2026-11-12

This study is trying to see how blockages in the heart's blood vessels affect the health and future of people with different types of heart muscle diseases.

More Ischemic Stroke trials

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment1600 (estimated)
SponsorUniversity Hospital, Grenoble
Academic / other
Locations1 site (La Tronche)
StatusRecruiting
StartedFebruary 8, 2018
Main results expectedFebruary 2028
Study endsFebruary 2028
Registry record updatedMay 19, 2022
Trial IDNCT03479580 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with ischemic, dilated, hypertrophic, or restrictive cardiomyopathy.

Probably not a fit

Patients who are pregnant, breastfeeding, or under legal protection will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry evaluates the long-term prognostic value of macrovascular and microvascular coronary artery stenoses in patients with various types of cardiomyopathy, including ischemic, hypertrophic, dilated, and restrictive forms. The study utilizes advanced imaging techniques such as coronary angiography, cardiac magnetic resonance, and single-photon emission computed tomography to assess the incidence and prognosis of bystander coronary artery disease and microvascular disease. Conducted across five centers in France, the study aims to clarify the impact of these conditions on patient outcomes.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of coronary artery disease's impact on cardiomyopathy prognosis, leading to improved patient management.

How similar studies have gone: While the study explores a novel approach to understanding the prognostic implications of coronary artery disease in cardiomyopathy, similar studies have shown promise in utilizing advanced imaging techniques for cardiovascular assessment.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Ischemic
* Dilated
* Hypertrophic
* Restrictive cardiomyopathy.

Exclusion Criteria:

* Pregnant women
* Breastfeeding women
* Patients under legal protection

Where it's running

  • University Hospital Grenoble
    La Tronche, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.